Coalition Against Major Diseases (CAMD)

See the following -

3Rs For Innovating Novel Antibiotics: Sharing Resources, Risks, And Rewards

Anthony D So, Quentin Ruiz-Esparza, Neha Gupta, Otto Cars | BMJ | April 3, 2012

The stream of new antibiotics is struggling to keep up with emerging bacterial resistance. Anthony So and colleagues examine what can be done to increase innovation... Read More »

Academic Sector Leverages Open-Source Concept in Development

Alex Philippidis | Genetic Engineering & Biotechnology News | October 11, 2011

Biopharma companies are pursuing open-innovation collaborations with an eye on speeding up research and discovery work. Academic and independent research institutions are also teaming up with industry to discover new treatments under this open-source model. Read More »